{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:39:51Z","timestamp":1778819991311,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jfma.2026.04.084","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:38:49Z","timestamp":1776857929000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vitamin D and calcium prevent bone loss in vitamin D-deficient chronic hepatitis B patients treated with tenofovir disoproxil fumarate: A randomized controlled trial"],"prefix":"10.1016","author":[{"given":"Thanapat","family":"Atthakitmongkol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Watcharasak","family":"Chotiyaputta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raweewan","family":"Lertwattanarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchai","family":"Sritippayawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wimolrak","family":"Bandidniyamanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7634-0843","authenticated-orcid":false,"given":"Tawesak","family":"Tanwandee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jfma.2026.04.084_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee, European Association for the study of the L. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2026.04.084_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.jfma.2026.04.084_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/apt.14497","article-title":"Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B","volume":"47","author":"Wong","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jfma.2026.04.084_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00535-020-01680-0","article-title":"Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review","volume":"55","author":"de Fraga","year":"2020","journal-title":"J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jfma.2026.04.084_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ki.2008.252","article-title":"Rosiglitazone reverses tenofovir-induced nephrotoxicity","volume":"74","author":"Liborio","year":"2008","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jfma.2026.04.084_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.46.3.716-723.2002","article-title":"Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors","volume":"46","author":"Birkus","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jfma.2026.04.084_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.2009.14","article-title":"Tenofovir renal toxicity targets mitochondria of renal proximal tubules","volume":"89","author":"Kohler","year":"2009","journal-title":"Lab Invest"},{"issue":"11","key":"10.1016\/j.jfma.2026.04.084_bib8","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jfma.2026.04.084_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.13659","article-title":"Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients","volume":"44","author":"Lampertico","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jfma.2026.04.084_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/COH.0000000000000248","article-title":"Tenofovir and bone health","volume":"11","author":"Grant","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"10.1016\/j.jfma.2026.04.084_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jvh.13053","article-title":"Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide","volume":"26","author":"Fong","year":"2019","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.jfma.2026.04.084_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2010.02.080","article-title":"Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density loss","volume":"394","author":"Grigsby","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jfma.2026.04.084_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0052","article-title":"Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir","volume":"28","author":"Masia","year":"2012","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.jfma.2026.04.084_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biopha.2017.11.037","article-title":"High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity","volume":"97","author":"Mingione","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.jfma.2026.04.084_bib15","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/AAC.01096-13","article-title":"Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?","volume":"57","author":"Havens","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jfma.2026.04.084_bib16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/aid.2009.0308","article-title":"Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users","volume":"26","author":"Childs","year":"2010","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.jfma.2026.04.084_bib17","article-title":"Tenofovir disoproxil fumarate is associated with a set-point variation in the calcium-parathyroid hormone-vitamin D axis: results from a German cohort","volume":"2018","author":"Noe","year":"2018","journal-title":"Adv Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.jfma.2026.04.084_bib18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/cid\/cir968","article-title":"Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial","volume":"54","author":"Havens","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2026.04.084_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5604\/16652681.1231580","article-title":"Lamivudine, entecavir, or tenofovir treatment of hepatitis B infection: effects on calcium, phosphate, FGF23 and indicators of bone metabolism","volume":"16","author":"Saeedi","year":"2017","journal-title":"Ann Hepatol"},{"issue":"8","key":"10.1016\/j.jfma.2026.04.084_bib20","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jfma.2026.04.084_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jfma.2026.04.084_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7326\/M14-1409","article-title":"Vitamin D and calcium attenuate bone loss with antiretroviral therapy initiation: a randomized trial","volume":"162","author":"Overton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jfma.2026.04.084_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3851\/IMP2755","article-title":"Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate","volume":"19","author":"Havens","year":"2014","journal-title":"Antivir Ther"},{"issue":"1","key":"10.1016\/j.jfma.2026.04.084_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1570162X18666200106150806","article-title":"Vitamin D and calcium supplement attenuate bone loss among HIVInfected patients receiving tenofovir disoproxil Fumarate\/Emtricitabine\/efavirenz: an open-label, randomized controlled trial","volume":"18","author":"Boontanondha","year":"2020","journal-title":"Curr HIV Res"},{"issue":"8","key":"10.1016\/j.jfma.2026.04.084_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/09540121.2019.1622631","article-title":"Antiretroviral-naive HIV-infected patients had lower bone formation markers than HIV-uninfected adults","volume":"32","author":"Wattanachanya","year":"2020","journal-title":"AIDS Care"},{"issue":"11","key":"10.1016\/j.jfma.2026.04.084_bib26","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.17219\/acem\/127684","article-title":"Effects of efavirenz and tenofovir on bone tissue in Wistar rats","volume":"29","author":"Matuszewska","year":"2020","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"10.1016\/j.jfma.2026.04.084_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/2230-8210.109659","article-title":"Dual energy X-ray absorptiometry: pitfalls in measurement and interpretation of bone mineral density","volume":"17","author":"Garg","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jfma.2026.04.084_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000227.pub3","article-title":"Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis","author":"Avenell","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2026.04.084_bib29","article-title":"Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe","volume":"340","author":"Group","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jfma.2026.04.084_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626004225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626004225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:23:32Z","timestamp":1778775812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626004225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"alternative-id":["S0929664626004225"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.04.084","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D and calcium prevent bone loss in vitamin D-deficient chronic hepatitis B patients treated with tenofovir disoproxil fumarate: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.04.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}